Kyverna Therapeutics, Inc. (KYTX)
NASDAQ: KYTX · Real-Time Price · USD
7.38
-0.54 (-6.82%)
Jul 28, 2026, 2:57 PM EDT - Market open
Kyverna Therapeutics Market Cap
Kyverna Therapeutics has a market cap or net worth of $448.67 million as of July 28, 2026. Its market cap has increased by 139.75% in one year.
Market Cap
448.67M
Enterprise Value
252.67M
1-Year Change
139.75%
Ranking
Category
Stock Price
$7.38
ChartMarket Cap Chart
Since the IPO on February 8, 2024, Kyverna Therapeutics's market cap has decreased from $898.10M to $448.67M, a decrease of -50.04%. That is a compound annual growth rate of -24.51%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 28, 2026 | 448.67M | -16.45% |
| Dec 31, 2025 | 537.02M | 232.60% |
| Dec 31, 2024 | 161.46M | -82.02% |
| Feb 8, 2024 | 898.10M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eikon Therapeutics | 481.83M |
| Ginkgo Bioworks Holdings | 480.79M |
| Cybin | 472.32M |
| Prothena Corporation | 458.09M |
| Valneva SE | 455.82M |
| Inhibikase Therapeutics | 455.33M |
| ProKidney | 453.09M |
| Cabaletta Bio | 438.62M |